C
MGNX icon

Covestor’s MacroGenics MGNX Stock Holding History

Covestor’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-55
Closed – – 2576
2025
Q4 		$0 Sell
55
-1
-2% -$2 ﹤0.01% 2545
2025
Q3 		$0 Hold
56
– – ﹤0.01% 2556
2025
Q2 		$0 Buy
56
+38
+211% +$55 ﹤0.01% 2522
2025
Q1 		$0 Buy
18
+1
+6% +$3 ﹤0.01% 2523
2024
Q4 		$0 Buy
17
+1
+6% +$4 ﹤0.01% 2533
2024
Q3 		$0 Buy
16
+10
+167% +$39 ﹤0.01% 2525
2024
Q2 		$0 Hold
6
– – ﹤0.01% 2540
2024
Q1 		$0 Buy
+6
New +$91 ﹤0.01% 2536
2022
Q1 		– Sell
-16
Closed – – 2304
2021
Q4 		$0 Buy
+16
New +$301 ﹤0.01% 2223

Other funds holding MGNX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Covestor's MGNX Position: Q1 2026 in Review

Covestor sold out of MacroGenics (MGNX) in Q1 2026, closing a stake of 55 shares.

Covestor first reported a position in MGNX in Q4 2021 and held it in 9 quarters. The position peaked at $0 in Q4 2025. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

  • Covestor reported no remaining MacroGenics position as of Q1 2026 after selling out during the quarter.
  • Covestor sold 55 MacroGenics shares in Q1 2026.
  • Covestor first reported a position in MacroGenics in Q4 2021 and held it in 9 quarters.
  • Covestor's MacroGenics position peaked at $0 in Q4 2025.
  • 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.